These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3798126)

  • 21. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
    Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
    Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
    Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Lentz SS; Brady MF; Major FJ; Reid GC; Soper JT
    J Clin Oncol; 1996 Feb; 14(2):357-61. PubMed ID: 8636744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
    Lai CH; Hsueh S; Chao AS; Soong YK
    Br J Obstet Gynaecol; 1994 Jun; 101(6):547-9. PubMed ID: 8018650
    [No Abstract]   [Full Text] [Related]  

  • 27. A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma.
    Creagan ET; Ingle JN; Schutt AJ; Schaid DJ
    Am J Clin Oncol; 1989 Apr; 12(2):152-5. PubMed ID: 2705405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of megestrol acetate and clomiphene citrate as supplemental medication in postmenopausal oestrogen replacement therapy.
    Kauppila A; Kivinen S; Leinonen P; Tuimala R; Vihko R; Ylöstalo P
    Arch Gynecol; 1983; 234(1):49-58. PubMed ID: 6660928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
    Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
    Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
    Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose megestrol acetate. A possible treatment for cachexia.
    Tchekmedyian NS; Tait N; Moody M; Aisner J
    JAMA; 1987 Mar; 257(9):1195-8. PubMed ID: 3806918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body-composition changes in patients who gain weight while receiving megestrol acetate.
    Loprinzi CL; Schaid DJ; Dose AM; Burnham NL; Jensen MD
    J Clin Oncol; 1993 Jan; 11(1):152-4. PubMed ID: 8418227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
    Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
    Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
    Kim MK; Seong SJ
    J Gynecol Oncol; 2014 Jul; 25(3):164-5. PubMed ID: 25045426
    [No Abstract]   [Full Text] [Related]  

  • 40. Megestrol acetate for the palliation of advanced ovarian carcinoma.
    Geisler HE
    Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.